Invention Grant
US07750018B2 Use of carboxiamidotriazole (CAI) orotate in macular degeneration
有权
使用羧甲氨喋呤（CAI）乳酸盐在黄斑变性
- Patent Title: Use of carboxiamidotriazole (CAI) orotate in macular degeneration
- Patent Title (中): 使用羧甲氨喋呤（CAI）乳酸盐在黄斑变性
-
Application No.: US11634422Application Date: 2006-12-06
-
Publication No.: US07750018B2Publication Date: 2010-07-06
- Inventor: Rashida A. Karmali
- Applicant: Rashida A. Karmali
- Applicant Address: US NY New York
- Assignee: Tactical Therapeutics, Inc
- Current Assignee: Tactical Therapeutics, Inc
- Current Assignee Address: US NY New York
- Agent Rashida A. Karmali
- Main IPC: A61K31/505
- IPC: A61K31/505
Abstract:
Method and composition of Carboxyamidotriazole orotate for treating age-related macular degeneration and other angiogenesis-dependent diseases.
Public/Granted literature
- US20080139592A1 Use of carboxiamidotriazole (CAI) orotate in macular degeneration Public/Granted day:2008-06-12
Information query
